WHO ICTRP trial
SAPPORO study to Prove the Effects of telmisartan and valsartan on Early morning…
JPRN-UMIN000003922 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000003922 |
|---|---|
| Public title | SAPPORO study to Prove the Effects of telmisartan and valsartan on Early morning blood pressure based on amlodipine treatment |
| Scientific title | SAPPORO study to Prove the Effects of telmisartan and valsartan on Early morning blood pressure based on amlodipine treatment - SPEED study |
| Primary sponsor | SPEED investigators |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not selected |
| Countries | Japan |
| Conditions | patients with essential hypertension |
| Interventions | amlodipine and telmisartan amlodipine and valsartan |
| Registration date | Jul 20, 2010 |
| Target size | 250 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: